OncoAlert Author: OncoAlert The latest in Oncology News, happenings and research.  Be a guest on this podcast Language: en-us Genres: Health & Fitness, Medicine Contact email: Get it Feed URL: Get it iTunes ID: Get it Get all podcast data

Listen Now...

VJ/OA Journal Club: LITESPARK 005 with Dr. Brian Rini & Dr. Tom Powles (KidneyCancer)
Episode 2
Thursday, 3 April, 2025

The phase 3 LITESPARK-005 trial evaluated patient-reported outcomes (PROs) for belzutifan, a HIF-2α inhibitor, versus everolimus in patients with advanced renal cell carcinoma previously treated with immune checkpoint and anti-angiogenic therapy. 

We also recommend:

Neuroanatomie
Dominique Hasboun

Depth of Anesthesia
David Hao, MD

Life Can Change In A Moment
Doctor Larry Burchett

Love Your Practice
Laura Mach

Covid 19 y H1N1
Fernanda Arenas

Od Bb 1
Gisela Castro

Biogenoma
Abigail Barrera

Historia clínica de la mujer gestante.
Aneli Maciel

MamiGinecoobstetra

The Physical Therapy Lab
Travis

The Problems We Face Podcast
Bede Marciari

Fake medicine.
Fake medicine